As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Critic At Large
Most Recent
More collaborators and more data are the key ingredients.
Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.
Novel observations can sometimes be correct for unexpected reasons.
A prescription for educating the public on the value of using animals in medical research
Advances in cell-culture technologies are paving the way to the complete elimination of animals from the laboratory.
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
The path to eradicating malaria in Africa involves much more than just a vaccine.
Subjects
- culture
- disease/medicine
- funding
- opinion
- policy
- public health
- regulation
- science policy
- science publishing
- techniques
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
